Routine 3D treatment planning: Opportunities, challenges, and hazards

Citation
Lb. Marks et al., Routine 3D treatment planning: Opportunities, challenges, and hazards, ONCOLOGY-NY, 14(8), 2000, pp. 1191-1201
Citations number
35
Categorie Soggetti
Oncology
Journal title
ONCOLOGY-NEW YORK
ISSN journal
08909091 → ACNP
Volume
14
Issue
8
Year of publication
2000
Pages
1191 - 1201
Database
ISI
SICI code
0890-9091(200008)14:8<1191:R3TPOC>2.0.ZU;2-K
Abstract
Three-dimensional (3D) treatment planning refers to the use of software and hardware tools to design and implement more accurate and conformal radiati on therapy. This is a major advance in oncology that should lead to the red uction of treatment-associated morbidity and facilitate safe dose escalatio n for many tumor sites. This technology affords the incorporation of physio logic and anatomic information into the treatment planning process, further enhancing our ability to improve the therapeutic ratio. However, as with a ny new technology, care must be taken when applying it in the clinic. The i ntroduction of 3D planning presents new challenges to existing quality assu rance systems. These need to be addressed to maintain patient safety. Based on our experience with over 1,500 patients treated at Duke University, the benefits, challenges, and hazards of routine 3D treatment planning are dis cussed.